Skip to content

Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy

Safety and Tolerability of Local Ischemic Post-conditioning in Patients With Acute Ischemic Stroke After Mechanical Thrombectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05153655
Acronym
PROTECT
Enrollment
18
Registered
2021-12-10
Start date
2021-12-15
Completion date
2022-08-15
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Keywords

acute ischemic stroke, ischemic postconditioning, endovascular thrombectomy

Brief summary

Ischemic post-conditioning is a neuroprotective strategy that has been proven to attenuate reperfusion injury in animal models of stroke. The purpose of this proof-of-concept study is to determine the safety and tolerability of ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.

Interventions

PROCEDURELocal ischemic post-conditioning

Direct local ischemic post-conditioning will be applied after successful recanalization of the culprit middle cerebral artery. Local ischemic post-conditioning consists of briefly repeated 4 cycles of occlusion and reperfusion (equal duration) of the initially occluded culprit middle cerebral artery using a balloon. The schedule of advancing duration is 0 1 2 3 4 5 min.

Sponsors

Capital Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-80 years; * Acute ischemic stroke caused by middle cerebral artery M1 segment occlusion; * Successful recanalization (mTICI 2b/3) after endovascular thrombectomy that confirmed by digital subtraction angiography; * Written informed consent provided by the patients or their legal relatives.

Exclusion criteria

* Known diagnosis or clinical suspicion of cerebral vasculitis or fibromuscular dysplasia; * Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning; * Stenting in the middle cerebral artery as rescue therapy during the thrombectomy procedures; * \> 2 times of balloon dilations as rescue therapy due to angioplasty during the thrombectomy procedures; * Moderate or severe residual stenosis (≥ 50%) of the culprit artery after recanalization; * Difficulty in complying with ischemic post-conditioning or other conditions that the investigator considered inappropriate for inclusion.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with major responseImmediately after intervention on the day of ischemic post-conditioningMajor response is any of the following: * Vessel perforation or rupture; * Reocclusion of the culprit vessel after post-conditioning; * Vessel dissection; * Severe vasospasm; * Ischemic post-conditioning related thrombotic events; * Rupture of the balloon used for post-conditioning. In the 3 + 3 design, 3 subjects are recruited for a given ischemic post-conditioning dose level. The trial is stopped if ≥ 2 of 3 subjects at a given dose level show major response. If only 1 of 3 subjects shows major response, 3 more subjects are recruited at a given dose level and a major response in any of them will stop the trial. Otherwise, same procedure is followed for the next ischemic post-conditioning dose level. Maximum tolerable dose will be the dose at the level before stopping of the trial.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026